期刊
CELL METABOLISM
卷 31, 期 6, 页码 1091-+出版社
CELL PRESS
DOI: 10.1016/j.cmet.2020.04.017
关键词
-
资金
- NIH [1R35HL135800, S10RR027050]
- Integrating Special Populations (ISP) Resource, CTSA, Columbia University [GG011557-26]
- CFF Postdoctoral fellowship RIQUEL [17F0/PG008837]
- M-AES mobility grant [MV16/00053]
- NCATS-NIH [UL1TR001873]
- FIS from ISCIII [PI16/01381]
- International Microbiome Centre
- Canada Foundation for Innovation [CFI-JELF 34986]
- [CD15/00125]
The bacterium Pseudomonas aeruginosa is especially pathogenic, often being associated with intractable pneumonia and high mortality. How P. aeruginosa avoids immune clearance and persists in the inflamed human airway remains poorly understood. In this study, we show that P. aeruginosa can exploit the host immune response to maintain infection. Notably, unlike other opportunistic bacteria, we found that P. aeruginosa alters its metabolic and immunostimulatory properties in response to itaconate, an abundant host-derived immunometabolite in the infected lung. Itaconate induces bacterial membrane stress, resulting in downregulation of lipopolysaccharides (LPS) and upregulation of extracellular polysaccharides (EPS). These itaconate-adapted P. aeruginosa accumulate lptD mutations, which favor itaconate assimilation and biofilm formation. EPS, in turn, induces itaconate production by myeloid cells, both in the airway and systemically, skewing the host immune response to one permissive of chronic infection. Thus, the metabolic versatility of P. aeruginosa needs to be taken into account when designing therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据